In 2018, Cannabis and related companies from Canada, USA foreign countries raised CDN $16 billion in equity and debt financing. Where did all this money come from?
In 2018, $10 billion cannabis investments (62% of the $16 billion total) can be traced back to funding sources.
In addition to Canadian and US investors, investors from 99 other countries participated in 2018 financings. US investors led with $6.03 billion (61%), almost doubling of the total amount invested by Canadian investors which amounted to $3.1 billion.
Top ten deals account for 50% of total amount in 2018
Top ten cannabis deals, all with size of $200 million or more, raised $8.07 billion accounting for 50% of the total amount raised.
Ranking | Company | Symbol(s) | Type of Financing |
1 | Canopy Growth Corporation | TSX: WEED; NYSE: CGC | Private Placement |
2 | Curaleaf Holdings, Inc. | CSE: CURA; OTCQX: CURLF | RTO Financing |
3 | Canopy Growth Corporation | TSX: WEED; NYSE: CGC | Debt Financing |
4 | Tilray, Inc. | NASDAQ: TLRY | Debt Financing |
5 | Acerage Holdings, Inc. | CSE: ACRG.U; OTCQX: ACRGF | RTO Financing |
6 | Harvest Health & Recreation Inc. | CSE: HARV; OTCQX: HRVSF | RTO Financing |
7 | Aphria Inc. | TSX/NYSE: APHA | Public Offering |
8 | Aurora Cannabis Inc. | TSX/NYSE: ACB | Public Offering |
9 | Tilray, Inc. | NASDAQ: TLRY | IPO Financing |
10 | Canopy Growth Corporation | TSX: WEED; NYSE: CGC | Public Offering |
The full report can be downloaded from financings.ca reports
Supporting data sheet for 2016 to 2018 can be purchased from CPE Media, contact us for details
Included: 1) monthly trends; 2) exchanges/private; 3) equity vs debt; 4) HQ with a full detailed listing; 5) major assets with a full detailed listing; 6) top 10 funding sources with a full detailed listing (2018 only); 7) 2018 top ten deals with investor or major jurisdiction investor information.